Oxaloacetic acid (also known as oxalacetic acid or OAA) is a crystalline organic compound with the chemical formula HO 2 CC (O)CH 2 CO 2 H. Oxaloacetic acid, in the form of its conjugate …

Oxalo Therapeutics is developing first-in-class therapeutics to treat rare renal diseases and prevent recurrent kidney stones. Primary hyperoxaluria is a monogenic autosomal recessive …

Oxalo Therapeutics is a committed to developing first-in-class therapeutics to treat and prevent diseases caused by hyperoxaluria and hyperoxalemia. We are a preclinical stage …

Sep 29, 2018 · Oxalo Therapeutics, a University of Chicago biotech startup, was awarded a $2.3 million grant to develop a first-of-its-kind drug to prevent kidney stones

Oxaloacetic acid, also known as oxalacetate, is a vital intermediate compound in the citric acid cycle, also known as the Krebs cycle. It is a four-carbon molecule produced during the …

Oxaloacetate has been found to act as an antioxidant, reduce inflammation in the body, and improve mitochondrial function, which is crucial for energy production. It has also been shown …

Sep 25, 2018 · Named after Oxalobacter formigenes, a gut bacteria linked to reduced risks of kidney stones, the company will receive the $2.3 million grant in two parts—one this month …

Jun 21, 2018 · Dr. Hatim Hassan, a University of Chicago nephrologist, is working on an alternative that won't have you racing to the restroom all day long. With Yang Zheng, he co …

Oxalo Therapeutics is developing first-in-class therapeutics to treat rare renal diseases and prevent recurrent kidney stones. University of Chicago assistant professor of medicine Hatim …